Cohort profile: Evaluation of the Methods and Management of Acute Coronary Events (EMMACE) longitudinal cohort
An erratum to this article was published (Eur Heart J Qual Care Clin Outcomes, 1 Mar 2024 ↗)
Authors' conclusion
EMMACE is a nationwide prospective cohort that will provide unique insights into fatal and non-fatal outcomes, medication adherence, and HRQoL following MI.
Study context
- Population
- Patients hospitalised with myocardial infarction (MI) at 77 hospitals in England (EMMACE-3 and −4), 1 Nov 2011–24 Jun 2015
- Participants
- 14,899 patients77 hospitals
Methodological detailsmulticentre, linked, longitudinal, Long-term follow-up via EMMACE-XL (27 Sep 2020–31 Mar 2022) and EMMACE-XXL (1 Jul 2021–1 Jul 2023)
- Multicentre
- Linked
- Longitudinal
- Long-term follow-up via EMMACE-XL (27 Sep 2020–31 Mar 2022) and EMMACE-XXL (1 Jul 2021–1 Jul 2023)
Main finding
As reported in the abstract
- Health-related quality of life (HRQoL) (EQ-5D-3L and visual analogue scale) collected at admission, 1, 6, 12 months and 10 years; plus medications, adherence, beliefs about medicines, information satisfaction, illness perceptions
- Data linked to Myocardial Infarction National Audit Project (MINAP), Hospital Episode Statistics and Office for National Statistics mortality data up to 2020
Observational data: associations, not effects.
Original publication
Cohort profile: Evaluation of the Methods and Management of Acute Coronary Events (EMMACE) longitudinal cohort. Eur Heart J Qual Care Clin Outcomes. Published 14 July 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →